Submit your Abstract to ALIVE 2022

Please read the Call for Abstracts submission guidelines before completing this form. Complete all applicable fields.  Submit this form using no later than 14th November 2021, 23h59 CET (FINAL EXTENSION).  You will receive confirmation of receipt of your submission within 48 hours.

ABSTRACT SUBMISSION IS NOW CLOSED

    1) Presenting author and correspondence information

    All correspondence will be sent to the attention of the presenting author at the email address listed below

    2) Disclosure of Relevant Financial Relationships

    2 a) Do you have relevant financial relationship(s) with commercial interest(s) occurring within the past 12 months related to the content of this abstract submission?

    YesNo

    If yes, complete this section. First, list the name(s) of the commercial interest (entities producing, marketing or reselling, or distributing health care goods or services consumed by, or used on, animals) from which you have received a financial benefit. For this purpose we consider the relevant financial relationships of your spouse or partner to be relevant and each should be listed below. Second, describe what you or your spouse/partner received (salary, honorarium, stock, etc). LEISHVET ALIVE DOES NOT want to know the amount received. Third, describe your role (consultant, speaker’s bureau, board member, stockholder, etc.).

    2b. In this lecture, do you talk about unlabeled use, or products/treatments that are not yet approved for use on animals?

    YesNo

    If Yes, please explain

    3) Co-Authors (if applicable)

    Do not duplicate the presenting author’s name. List co-authors in the order they should appear if published.

    Co-Authors Disclosure

    Co-Author 1

    Co-Author 2

    Co-Author 3

    Co-Author 4

    Co-Author 5

    Co-Author 6

    Co-Author 7

    Co-Author 8

    Co-Author 9

    Co-Author 10

    Co-Author 11

    Co-Author 12

    4) Presenter’s Primary Practice Setting

    Approval attestation from a Residency Training Director or Supervisor must accompany the submission for student, resident, or fellow submissions. Please select.

    6) Interest Topic

    Please select all areas of interest addressed by the abstract (see Guidelines for details)

    EpidemiologyImmunologyGenomicsClinical and diagnosticTreatmentPreventionOne Health framework

    6) Submission

    Please select they type of presentation you wish to give.
    Note that only .doc or .docx formats are accepted. The maximum file size is 10Mb.
    (See Guidelines for instructions on document content and types)

    OralPoster

    Upload your file:

    If you believe there might be a conflict of interest, please state below: